Showing posts with label broad drug patent claims. Show all posts
Showing posts with label broad drug patent claims. Show all posts

Friday, March 17, 2023

Dog Toys, Drugs Lead Supreme Court’s High-Stakes IP Arguments; Bloomberg Law, March 17, 2023

Kelcee Griffis and Kyle Jahner, Bloomberg LawDog Toys, Drugs Lead Supreme Court’s High-Stakes IP Arguments

"The US Supreme Court is set to weigh three high-profile intellectual property cases in a seven-day stretch testing the bounds of branded parodies, broad drug patent claims, and international application of trademark law.

The arguments could result in rulings with wide-ranging impacts on areas including First Amendment expression, pharmaceutical research and development, and damages calculations. The US solicitor general will argue in all three cases, signaling the government’s strong interest in their outcomes.

Here’s what to expect during the high court’s blockbuster IP week."